StockClub

SRNE

SRNESorrento Therapeutics, Inc.$ --
Sorrento Therapeutics, Inc.

Sorrento Therapeutics, Inc.

SRNE

$ -

-

Review earnings summary, surprise history, and upcoming forecasts.

wallet
Earnings Summary
Updated: 06/30/2023FY2023 Q2
Revenue
15M USD
YoY +31.1%
Operating Income
-77M USD
YoY +15.9%
Net Income
-95M USD
YoY +56.6%
EPS
-0.17$
YoY +69.1%

Revenue

$31.3M
FY2021 Q3$39.8M
$39.8M
Q3
FY2021 Q4$52.9M
$52.9M
Q4
FY2022 Q1$18.4M
$18.4M
Q1
FY2022 Q2$29.8M
$29.8M
Q2
FY2022 Q3$47.2M
$47.2M
Q3
FY2022 Q4$62.8M
$62.8M
Q4
FY2023 Q1$16.3M
$16.3M
Q1
FY2023 Q2$31.3M
$31.3M
Q2
Actual
+$1.4M (+4.8%)

Net Income

$-234.8M
FY2021 Q3$-283.9M
$-283.9M
Q3
FY2021 Q4$-428.3M
$-428.3M
Q4
FY2022 Q1$-40.8M
$-40.8M
Q1
FY2022 Q2$-260.4M
$-260.4M
Q2
FY2022 Q3$-351.1M
$-351.1M
Q3
FY2022 Q4$-574.7M
$-574.7M
Q4
FY2023 Q1$-139.6M
$-139.6M
Q1
FY2023 Q2$-234.8M
$-234.8M
Q2
Actual
+$25.5M (+9.8%)

Surprise History

Actual RevenueAnalyst Estimate
FY2017BEAT
Actual:$151.9M
Est:$144.2M
FY2017BEAT
$151.9M
FY2018BEAT
Actual:$21.2M
Est:$17.8M
FY2018BEAT
$21.2M
FY2019BEAT
Actual:$31.4M
Est:$25M
FY2019BEAT
$31.4M
FY2020MISS
Actual:$40M
Est:$1B
FY2020MISS
$40M
FY2021IN-LINE
Actual:$52.9M
Est:$52.9M
FY2021IN-LINE
$52.9M
FY2022BEAT
Actual:$62.8M
Est:$42.2M
FY2022BEAT
$62.8M

Analyst Estimates